FTO and hepatocellular carcinoma: The presence of elevated levels of circGPR137B relies on FTO-mediated m6A modification and thwarts HCC tumorigenesis and metastasis through the circGPR137B/miR-4739/FTO regulatory feedback loop (Fig. 4B) [108].